期刊文献+

肾康注射液联合血栓通注射液治疗早期糖尿病肾病临床观察 被引量:3

Therapeutic Effect of Shenkang Injection Plus Xueshuantong Injection for Early Diabetic Nephropathy
在线阅读 下载PDF
导出
摘要 目的:观察常规西药治疗基础上加用肾康注射液及血栓通注射液治疗早期糖尿病肾病的临床疗效。方法:选取80例早期糖尿病肾病患者,以数字表格法分为治疗组与对照组各40例,对照组常规治疗,治疗组在常规治疗基础上加用肾康注射液、血栓通注射液静脉滴注,每天1次,疗程2周,观察治疗前后血尿素氮(BUN)、肌酐(SCr)、尿微量白蛋白(MA)、β2-微球蛋白(β2-MG)变化及中医证候评分变化。结果:治疗前2组中医证候评分比较,差异无显著性意义(P>0.05),2组治疗后均较治疗前下降,与治疗前比较,差异有显著性意义(P<0.05),治疗组低于对照组,组间比较差异有显著性意义(P<0.05)。2组患者治疗前BUN、SCr、MA、β2-MG比较,差异均无显著性意义(P>0.05),2组治疗后BUN、SCr、MA指标均较治疗前下降,与治疗前比较,差异均有显著性意义(P<0.05),β2-MG治疗组治疗后较治疗前下降,与治疗前比较,差异有显著性意义(P<0.05),对照组治疗前后比较,差异无显著性意义(P>0.05),治疗后BUN、SCr、MA、β2-MG组间比较,治疗组均较对照组为低(P<0.05)。结论:肾康注射液联合血栓通注射液治疗早期糖尿病肾病能明显改善肾功能,疗效较好,值得推广。 Objective: To observe the combination of Shenkang injection and Xueshuantong injection on the basis of conventional western medicine in treating early diabetic nephropathy. Methods: Eighty patients with early diabetic nephropathy were divided into treatment group and control group by the random number, 40 cases in each group. The control group was given conventional western medical treatment, and the treatment group was given intravenous injection of Shenkang injection and Xueshuantong injection once daily on the basis of conventional treatment. The treatment course lasted 2 weeks. Before and after treatment, the changes of blood urea nitrogen (BUN), serum creatinine (SCr), urinary micro-amount albumin(MA), and beta 2-microglobulin(β2-MG) as well as the scores of traditional Chinese medical symptoms were observed. Results: The scores of traditional Chinese medical symptoms were similar in both group before treatment(P 〉 0.05), then were decreased after treatment(P〈 0.05), and were lower in the treatment group than those in the control group(P〈 0.05). The differences of BUN, SCr, MA and β2-MG were insignificant in both groups before treatment(P〉0.05). After treatment, BUN, SCr, and MA were decreased in both groups(P〈0.05), and β2-MG was decreased in the treatment group(P〈 0.05) but did not change much in the control group(P 〉 0.05). The levels of BUN, SCr, MA and β2-MG were lower in the treatment group in comparison with the control group after treatment(P 〈 0.05). Conclusion. Shenkang injection and Xueshuantong injection on the basis of conventional western medicine is effective in treating early diabetic nephropathy through significantly improving the renal function.
作者 周雪艳
出处 《新中医》 CAS 2014年第1期112-114,共3页 New Chinese Medicine
关键词 糖尿病肾病 早期 肾康注射液 血栓通注射液 Diabetic nephropathy., Early stage Shenkang injection Xueshuantong injection
  • 相关文献

参考文献9

二级参考文献126

共引文献99

同被引文献29

  • 1马继伟,王宏天,刘培娜,张翥.肾康注射液治疗早期糖尿病肾病的临床观察[J].天津中医药,2013,30(9):526-528. 被引量:11
  • 2Cho EH,Kim EH,Kim WG,et a1.Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes[J].Korean Diabetes J,2010,34(3):200-206.
  • 3Tomaru T,Steger DJ,Lefterova MI,et al.Adipocyte-specific expression of murine resistin is mediated by synergism between peroxisome proliferator-activated receptorγand CCAAT/enhancer-binding proteins[J].J Biol Chem,2009,284(10):6116-6125.
  • 4Mojiminyi OA,Abde Ua N,George S.Eraluation of serun Cystatin C and chromogranin A as markers of nephropathy in patients with type2 diabetes mellitus[J].Scand J CIin Lab Invest,2000,60(6):483-489.
  • 5Solano MP,Goldberg RB.Management of dyslipidemia in diabetes[J].Cardiol Rev,2006,14(3):125-135.
  • 6Nishikawa T, Brownlee M, Araki E. Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy [ J ]. J Diabetic Invest,2015,6(2) :137-139.
  • 7Parving HH, Smidt UM, Andersen AR, et al. Early aggressive an- tihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy [ J ]. The Lancet, 1983,321 ( 8335 ) :1175-1179.
  • 8Zhou G, Cheung AK, Liu X, et al. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation [ J ]. Clin Sci, 2014,126 (10) :707-720.
  • 9巴应贵,白光辉.胱抑素C和同型半胱氨酸与早期糖尿病肾病的关系[J].临床医学,2010,30(2):118-120. 被引量:19
  • 10赵胜,杨传经.肾康注射液治疗早期糖尿病肾病40例的疗效[J].中国新药杂志,2010,19(10):853-854. 被引量:21

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部